Detalhe da pesquisa
1.
A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study).
Lancet Reg Health Am
; 21: 100497, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192953
2.
An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen.
N Biotechnol
; 72: 11-21, 2022 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953030
3.
Active component of a GnRH based vaccine binds to natural GnRH receptors in Dunning R3327-G cell line and human prostate carcinoma vesicles.
J Exp Ther Oncol
; 6(4): 279-84, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18038761
4.
Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome.
Biomed Res Int
; 2017: 2923759, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28904951
5.
Registro sanitario de Heberprot-P®, medicamento biotecnológico innovador para el tratamiento de las úlceras del pie diabético / Sanitary registration of Heberprot-P®, an innovative biotechnological drug for the treatment of diabetic foot ulcers
Rev. cuba. salud pública
; 47(4)dic. 2021.
Artigo
em Espanhol
| LILACS, CUMED | ID: biblio-1409254